PD-1 inhibitors in endometrial cancer

Oncotarget. 2017 Nov 21;8(63):106169-106170. doi: 10.18632/oncotarget.22583. eCollection 2017 Dec 5.

Authors

Romualdo Barroso-Sousa¹, Patrick A Ott¹

Affiliation

¹ Patrick A. Ott: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

No abstract available

Keywords: PD-1 inhibition; POLE; endometrial cancer; immunotherapy; microsatellite instability-high.

Publication types

Editorial